Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Vivaspharmacological

Phys Vivas · pharmacological

Paracetamol Toxicity — Viva Defence

Structured DCE viva for paracetamol toxicity: late single acute overdose with hepatotoxicity, ANZ nomogram line, acetylcysteine regimens, Yarema reactions, O'Grady markers and Bernal lactate, staggered contrast.

2 min readSource-verified ·

Target exams

FRACP DCEMRCP PACES
On this page
Study tools

Target exams

FRACP DCEMRCP PACES
Prompt
Structured DCE viva for paracetamol toxicity: late single acute overdose with hepatotoxicity, ANZ nomogram line, acetylcysteine regimens, Yarema reactions, O'Grady markers and Bernal lactate, staggered contrast.

Paracetamol Toxicity — Viva Defence

Long Case Viva Defence

The scenario

A 38-year-old man presents 14 hours after a single large paracetamol ingestion during an alcohol binge. He is drowsy, icteric, and tender in the right upper quadrant, with a liver flap. AST and ALT are in the thousands, INR 3.4, creatinine 180 micromol/L, arterial pH 7.32, arterial lactate 4.2 mmol/L, glucose 3.1 mmol/L, paracetamol 90 mg/L. [17]

Opening statement (SASPOP)

"This is a late single acute paracetamol overdose with established hepatotoxicity — transaminitis, coagulopathy, hypoglycaemia, mild encephalopathy, acute kidney injury — in a man with alcohol use disorder. The nomogram still describes a single known-time ingestion, but he is already injured so I am not waiting on a plot: I start intravenous acetylcysteine now, extend it while injury persists, and triage transplant using O'Grady's pH, prothrombin time and creatinine plus Bernal lactate. Chronic alcohol is a comorbidity, not a second nomogram line." [17][7][3][5][13]

Problem list

  1. Late single acute overdose with established hepatotoxicity. [17][1]
  2. Alcohol use disorder — withdrawal and nutrition; Rumack found no consistent chronic-alcohol difference in hepatotoxicity. [13]
  3. Transplant triage — pH 7.32 is not yet below 7.30; lactate 4.2 mmol/L is above Bernal's early 3.5 mmol/L threshold. [3][5]
  4. Deliberate self-harm — psychiatry once medically stable. [17]

Integrated management plan

Antidote: Start NAC now. ANZ current: Chiew two-bag 200 mg/kg over 4 hours then 100 mg/kg over 16 hours. Classic three-bag remains the exam comparator: 150 mg/kg over 15 minutes or 1 hour, 50 mg/kg over 4 hours, 100 mg/kg over 16 hours. Keays continued until recovery from encephalopathy or death; survival 48% versus 20%. Charcoal is futile at 14 hours (position paper: consider up to one hour, not routinely). [11][7][4][12]

Monitoring: Prothrombin time, creatinine, arterial pH, lactate, glucose. O'Grady poor prognosis: pH below 7.30, prothrombin time greater than 100 s, creatinine greater than 300 micromol/L. Bernal lactate identified non-survivors at a median 4 versus 10 hours. [3][5]

Reactions: Yarema 8.2% of 6,455 courses; 75.4% cutaneous; 95.4% in the first 5 hours; antihistamine in 92% of treated reactions. Stop, treat, restart slower. [10]

Probing questions

Q: Urticaria and wheeze during the first bag? Stop the infusion, treat the anaphylactoid reaction, restart more slowly. Yarema: most reactions are cutaneous and early; higher paracetamol concentrations were associated with fewer reactions (OR 0.79). [10]

Q: pH 7.28, prothrombin time greater than 100 s, creatinine 310, grade 3 encephalopathy? He now meets O'Grady poor-prognosis markers. Urgent liver-unit referral; continue NAC (Keays). Do not convert the 1989 paper into an unsourced "INR above 6.5". [3][4]

Q: How does lactate help? Validation-sample thresholds 3.5 mmol/L early (67%/95%) and 3.0 mmol/L after fluids (76%/97%); earlier identification than KCH criteria (4 versus 10 hours). [5]

Q: Staggered over three days instead? Nomogram invalid. UK CHM: treat all staggered and uncertain ingestions. Craig: 24.3% of a severe-injury cohort were staggered, mortality 37.3% versus 27.8%; consider early specialist transfer. [8][6][11]

Q: Activated charcoal? Fifty grams in volunteer data; consider up to one hour if the airway is protected; not routine; no evidence of improved clinical outcome. [12]


Physician Medicine Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References13ShowHide
  1. [1]Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning Br Med J, 1979.PMID 519312
  2. [2]Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) N Engl J Med, 1988.PMID 3059186
  3. [3]O'Grady JG, Alexander GJ, Hayllar KM, Williams R Early indicators of prognosis in fulminant hepatic failure Gastroenterology, 1989.PMID 2490426
  4. [4]Keays R, Harrison PM, Wendon JA, Forbes A, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial BMJ, 1991.PMID 1954453
  5. [5]Bernal W, Donaldson N, Wyncoll D, Wendon J Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study Lancet, 2002.PMID 11867109
  6. [6]Craig DG, Bates CM, Davidson JS, Martin KG, et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity Br J Clin Pharmacol, 2012.PMID 22106945
  7. [7]Bateman DN, Dart RC, Dear JW, Prescott LF, et al. Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver Clinical Toxicology (Philadelphia), 2023.PMID 38197864
  8. [8]Bateman DN, Carroll R, Pettie J, Yamamoto T, et al. Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment Br J Clin Pharmacol, 2014.PMID 24666324
  9. [10]Yarema M, Chopra P, Sivilotti MLA, Johnson D, et al. Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning J Med Toxicol, 2018.PMID 29423816
  10. [11]Chiew AL, Reith D, Pomerleau A, Wong A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand Med J Aust, 2020.PMID 31786822
  11. [12]Chyka PA, Seger D, Krenzelok EP, Vale JA, et al. Position paper: Single-dose activated charcoal Clin Toxicol (Phila), 2005.PMID 15822758
  12. [13]Rumack BH, Peterson RC, Koch GG, Amara IA Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment Arch Intern Med, 1981.PMID 7469629
  13. [17]Hodgman MJ, Garrard AR A review of acetaminophen poisoning Crit Care Clin, 2012.PMID 22998987
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousOpioid, Benzodiazepine and Alcohol Withdrawal — Viva DefencepharmacologicalNextPharmacokinetics in Organ Failure — Viva Defencepharmacological